Medefil Incorporated FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Apr 21, 2025
  • Last warning letter 2010
Inspections 11 3 OAI
Recalls 1 0 Class I (0%)
Warning letters 1 Latest Jun 10, 2010
510(k) clearances 7 Latest Sep 20, 2012

Medefil Incorporated has 1 FDA recall, 11 inspections, 7 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Medefil Incorporated, the most recent on Jun 10, 2010.

What these totals cover: FDA records filed under the name "Medefil Incorporated" and its spelling variant "Medefil".

Latest recall
Z-1149-2014 · Class III · Feb 19, 2014
Latest inspection
Apr 21, 2025 · VAI
Latest 510(k)
Sep 20, 2012

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances7Nov 22, 2026File dated Nov 18, 2026Current
Inspections11Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Medefil Incorporated's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Medefil Incorporated: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510000
202400000
202300000
202200000
202100000
202000000
201900000
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Medefil Incorporated as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Medefil Incorporated yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Medefil Incorporated FDA Warning Letters

1 warning letter on Jun 10, 2010.

IssuedSubjectIssuing officeClose-out letter
Jun 10, 2010 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

1 recall record on Feb 19, 2014.

NumberClassProductDate
Z-1149-2014Class IIIHeparin I.V. Flush Syringe is available is pre-filled polypropylene syringes, 100 units/mL, 3 mL…Feb 19, 2014

Recent FDA inspections

11 inspections from Feb 19, 2009 to Apr 21, 2025.

DateSiteProductClassificationFEI
Apr 21, 2025Glendale Heights, ILDrugsVoluntary Action Indicated (VAI)3001677091
Mar 29, 2018Glendale Heights, ILDrugsVoluntary Action Indicated (VAI)3001677091
Jun 17, 2016Glendale Heights, ILDrugsVoluntary Action Indicated (VAI)3001677091
Sep 15, 2014Glendale Heights, ILDevicesVoluntary Action Indicated (VAI)3001677091
Dec 20, 2012Glendale Heights, ILDrugsVoluntary Action Indicated (VAI)3001677091
Aug 22, 2012Glendale Heights, ILDrugsNo Action Indicated (NAI)3001677091
May 25, 2012Glendale Heights, ILDevicesVoluntary Action Indicated (VAI)3001677091
Sep 6, 2011Glendale Heights, ILDrugsOfficial Action Indicated (OAI)3001677091
Jan 31, 2011Glendale Heights, ILDevicesOfficial Action Indicated (OAI)3001677091
Feb 11, 2010Glendale Heights, ILDevicesOfficial Action Indicated (OAI)3001677091
Feb 19, 2009Glendale Heights, ILDevicesVoluntary Action Indicated (VAI)3001677091
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Medefil Incorporated: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jun 10, 2010.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3001677091Glendale Heights, IL11Apr 21, 2025

Recent 510(k) clearances

7 510(k) clearances from Feb 25, 2000 to Sep 20, 2012.

K-NumberDeviceDate
K121262MEDEFLUSH NORMAL SALINE I.V. FLUSH SYRINGE-STERILE FIELD READYSep 20, 2012
K092491MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE 1 UNIT/ML; 10 UNITS/ML; AND 100 UNITS/ML IN VARIOUS FILL SIZESFeb 3, 2010
K091583MEDEFIL'S NORMAL SALINE I.V. FLUSH SYRINGEJan 28, 2010
K020996MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE IN VARIOUS FILL SIZES - 1 ML FILL IN 6 ML SYRINGE LL; 2 ML FILL…Jun 24, 2002
K020999MEDEFIL'S NORMAL SALINE FLUSH SYRINGE IN VARIOUS FILL SIZES - 1 ML FILL IN 6 ML SYRINGE LL; 2 ML…Jun 20, 2002
K993518MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE, IN VARIOUS FILL SIZES - 1 ML FILL IN 3 ML SYRINGE LL; 1 ML…Jun 12, 2000
K993515MEDEFIL'S NORMAL SALINE FLUSH SYRINGE, IN VARIOUS FILL SIZES - 1 ML FILL IN 3 ML SYRINGE LL; 1 ML…Feb 25, 2000

Medefil Incorporated and the FDA: common questions

Has Medefil Incorporated received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Medefil Incorporated. The most recent is dated Jun 10, 2010.

Has Medefil Incorporated received an FDA Form 483?

FDA has not published a Form 483 for "Medefil Incorporated" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Medefil Incorporated?

The most recent FDA inspection on file ended Apr 21, 2025 at Glendale Heights, IL and was classified VAI. FDA has 11 inspections of Medefil Incorporated on file, 3 of them classified OAI (official action indicated).

Has Medefil Incorporated had an FDA recall?

Yes. Medefil Incorporated has 1 FDA recall on record. The most recent started Feb 19, 2014.

Need more than this page shows? Ask about Medefil Incorporated in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.